NCT01261247 2022-05-24Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaMayo ClinicPhase 2 Completed41 enrolled 8 charts
NCT01075321 2020-10-22Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin LymphomaMayo ClinicPhase 1/2 Completed58 enrolled 12 charts
NCT01239875 2020-01-14Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin LymphomaMayo ClinicPhase EARLY_PHASE1 Completed16 enrolled
NCT00389818 2018-06-06Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's LymphomaAIDS Malignancy ConsortiumPhase 2 Completed43 enrolled 7 charts
NCT01682044 2017-10-09Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone LymphomaRoswell Park Cancer InstitutePhase 2 Completed20 enrolled 11 charts
NCT00720135 2015-06-08Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin LymphomaCity of Hope Medical CenterPhase 1 Completed9 enrolled
NCT00361049 2010-11-05Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell TransplantCase Comprehensive Cancer CenterPhase 1 Completed49 enrolled